Assessing cancer drug combination efficacy across 900+PRISM cell lines in a multiplexed screening assay

被引：0
|
作者：
George, Ashish Bino
Nair, Shiker
Kocak, Mustafa
Nguyen, Ellen
Kalathungal, Alvin
Fazio, Anthony
Ponsi, Cole
Golabi, Aydin
Ronan, Melissa A.
Rees, Matthew G.
Roth, Jennifer A.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4560
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pitavastatin and prednisolone, novel drug combination, display significant synergy in ovarian cancer cell lines
    Abdullah, M. I.
    Khanim, F.
    Richarson, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S150 - S150
  • [22] A triple-drug combination induces apoptosis in cervical cancer-derived cell lines
    Delgado-Waldo, Izamary
    Contreras-Romero, Carlos
    Salazar-Aguilar, Sandra
    Pessoa, Joao
    Mitre-Aguilar, Irma
    Garcia-Castillo, Veronica
    Perez-Plasencia, Carlos
    Jacobo-Herrera, Nadia Judith
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
    Ribeiro, Eduarda
    Araujo, Diana
    Pereira, Mariana
    Lopes, Bruna
    Sousa, Patricia
    Sousa, Ana Catarina
    Coelho, Andre
    Rema, Alexandra
    Alvites, Rui
    Faria, Fatima
    Oliveira, Claudia
    Porto, Beatriz
    Mauricio, Ana Colette
    Amorim, Irina
    Vale, Nuno
    BIOMEDICINES, 2023, 11 (03)
  • [24] Combination of static magnetic field and cisplatin in order to reduce drug resistance in cancer cell lines
    Jalali, Amir
    Zafari, Jaber
    Jouni, Fatemeh Javani
    Abdolmaleki, Parviz
    Shirazi, Farshad H.
    Khodayar, Mohammad Javad
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2019, 95 (08) : 1194 - 1201
  • [25] A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level
    Vis, Daniel J.
    Jaaks, Patricia
    Aben, Nanne
    Coker, Elizabeth A.
    Barthorpe, Syd
    Beck, Alexandra
    Hall, Caitlin
    Hall, James
    Lightfoot, Howard
    Lleshi, Ermira
    Mironenko, Tatiana
    Richardson, Laura
    Tolley, Charlotte
    Garnett, Mathew J.
    Wessels, Lodewyk F. A.
    CELL REPORTS MEDICINE, 2024, 5 (08)
  • [26] UTILIZING HIGH-THROUGHPUT SCREENING PLATFORMS FOR PROFILING DRUG SENSITIVITY ACROSS MULTIPLE CANCER CELL LINES TO UNLOCK NEW TARGETED THERAPIES IN GLIOBLASTOMA
    Morelli, M.
    Carli, F.
    Lessi, F.
    Bisceglia, L.
    Franceschi, S.
    Aretini, P.
    Pasqualetti, F.
    Gambacciani, C.
    Pieri, F.
    Grimod, G.
    Santonocito, O.
    Di Stefano, A.
    Raimondi, F.
    Mazzanti, C.
    NEURO-ONCOLOGY, 2024, 26 : V61 - V62
  • [27] Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell lines
    Koras, Krzysztof
    Kizling, Ewa
    Juraeva, Dilafruz
    Staub, Eike
    Szczurek, Ewa
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell lines
    Krzysztof Koras
    Ewa Kizling
    Dilafruz Juraeva
    Eike Staub
    Ewa Szczurek
    Scientific Reports, 11
  • [29] A multiplexed enzymatic repair assay on biochip reveals a functional DNA repair signature in cancer cell lines exposed to cytotoxic anticancer drugs
    Sauvaigo, Sylvie
    Forestier, Anne
    Sarrazy, Fanny
    Caillat, Sylvain
    Vandenbrouck, Yves
    CANCER RESEARCH, 2013, 73 (08)
  • [30] Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines
    Soleiman, Morvarid
    Fathi-Roudsari, Mehrnoosh
    Khajeh, Khosro
    Maghsoudi, Amir
    CANCER INVESTIGATION, 2024, 42 (04) : 319 - 332
12345